Form 4: Xylem Executive McGann Reports Significant Equity Awards

Xylem Inc.'s EVP & President, Michael J. McGann, reported multiple acquisitions of common stock and stock options, primarily from vesting performance-based units and new awards.

Summary

• Michael J. McGann, EVP & President, MCS, acquired 1,966 shares of Xylem common stock on March 1, 2026, from the vesting of performance-based stock units tied to Total Shareholder Return (TSR), at a price of $128.98 per share.
• An additional 1,622 shares were acquired on March 1, 2026, from the vesting of performance-based stock units linked to Adjusted EBITDA, also at $128.98 per share.
• Further acquisitions on March 1, 2026, included 1,103 shares from Revenue-based performance units and 489 shares from ESG performance-based units, both at $128.98 per share.
• On March 2, 2026, McGann received an award of 1,610 restricted stock units (RSUs) at a price of $0, which are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
• McGann also received an award of 5,739 non-qualified stock options on March 2, 2026, with an exercise price of $128.98, vesting in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029, and expiring on March 2, 2036.
• To cover tax liabilities related to the vesting of various stock units, McGann disposed of a total of 2,796 shares of common stock at $128.98 per share on March 2, 2026.
• Following these transactions, McGann beneficially owns 12,225 shares of common stock and 5,739 non-qualified stock options.
• The reported beneficial ownership of common stock includes additional shares due to dividend reinvestment.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive indicator of executive retention and alignment, as the executive is receiving new awards and successfully vesting prior performance-based grants, reflecting achievement of company goals.

Positives

• Executive Michael J. McGann successfully met performance criteria (TSR, Adjusted EBITDA, Revenue, ESG) for previously granted stock units, leading to the acquisition of 5,180 shares of common stock.
• The executive received new equity awards, including 1,610 restricted stock units and 5,739 non-qualified stock options, indicating continued long-term incentive alignment with company performance.
• The vesting of performance-based units demonstrates the company's achievement of key strategic and financial objectives.

Negatives

• A total of 2,796 shares of common stock were disposed of to cover tax liabilities, representing a reduction in direct share ownership.

Future Outlook

The executive's newly awarded restricted stock units and non-qualified stock options are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029, indicating future equity accumulation tied to continued employment and potential performance.

Industry Context

StockSavvy.ai notes that executive equity awards and vesting events are standard practice across industries to align management incentives with shareholder interests. The use of performance-based metrics like TSR, Adjusted EBITDA, Revenue, and ESG reflects a common trend in executive compensation design to link pay to a broad range of strategic objectives.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards and new grants aligns executive incentives with shareholder value creation, but also represents a form of dilution through new share issuance or potential future share issuance upon option exercise.
• Employees: The compensation structure for a key executive can set a precedent or reflect the broader compensation philosophy within the company.

Next Steps

• First vesting increment of 1,610 restricted stock units and 5,739 non-qualified stock options on March 1, 2027.
• Second vesting increment of 1,610 restricted stock units and 5,739 non-qualified stock options on March 1, 2028.
• Third vesting increment of 1,610 restricted stock units and 5,739 non-qualified stock options on March 1, 2029.
• Expiration of non-qualified stock options on March 2, 2036.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, including the vesting of performance-based awards and the grant of new equity incentives. While it indicates the executive's continued commitment and the achievement of past performance targets, it does not provide new fundamental information about the company's operational or financial performance that would warrant a change in investment recommendation. It primarily reflects expected compensation activities.

Keywords

Xylem Inc., XYL, Insider Trading, Form 4, Executive Compensation, Stock Options, Restricted Stock Units, Performance-Based Awards, Michael J. McGann, Equity Awards, SEC Filing